Touchlight and LeninBio announce link up

LenioBio, a German biotech company focused on cell-free protein production, and UK-based enzymatic DNA production Touchlight have announced a supply agreement.

The deal is aimed at leveraging the capabilities of Touchlight’s rapid enzymatic doggybone DNA (dbDNA), to achieve a new level of speed in vaccine development and manufacture, in the context of LenioBio’s CEPI grant. 

LenioBio’s recently announced CEPI-funded project aims to showcase the capacity of its proprietary plant-based, cell-free ALiCE (almost living cell-free expression) technology to significantly accelerate vaccine development.